About Istituto Nazionale dei Tumori , Divisione di Oncologia Medica B
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at Istituto Nazionale dei Tumori , Divisione di Oncologia Medica B
During the past decade, Istituto Nazionale dei Tumori , Divisione di Oncologia Medica B conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Istituto Nazionale dei Tumori , Divisione di Oncologia Medica B"
#1 collaborator was "Clinical Trials Promoting Group (APRIC/CTPG)" with 1 trials as a collaborator, "Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente" with 1 trials as a collaborator, "Gruppo Oncologico Italia Meridionale" with 1 trials as a collaborator, "Gruppo Oncologico Italiano di Ricerca Clinica(GOIRC)" with 1 trials as a collaborator and "Gruppo Oncologico del Lazio (GOL)" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were
collaborators in the rest 10 trials.
Clinical Trials Conditions at Istituto Nazionale dei Tumori , Divisione di Oncologia Medica B
According to Clinical.Site data, the most researched conditions in "Istituto Nazionale dei Tumori , Divisione di Oncologia Medica B" are
"Breast Cancer" (4 trials), "Ovarian Cancer" (3 trials), "Advanced Non-Small Cell Lung Cancer" (2 trials), "Advanced Non-small Cell Lung Cancer" (1 trials) and "Endometrial Cancer" (1 trials). Many other conditions were trialed in "Istituto Nazionale dei Tumori , Divisione di Oncologia Medica B" in a lesser frequency.
Clinical Trials Intervention Types at Istituto Nazionale dei Tumori , Divisione di Oncologia Medica B
Most popular intervention types in "Istituto Nazionale dei Tumori , Divisione di Oncologia Medica B" are "Drug" (14 trials). Other intervention types were less common.
The name of intervention was led by "carboplatin" (5 trials), "gemcitabine" (5 trials), "cisplatin" (4 trials), "docetaxel" (4 trials) and "capecitabine" (3 trials). Other intervention names were less common.
Clinical Trials Genders at Istituto Nazionale dei Tumori , Divisione di Oncologia Medica B
The vast majority of trials in "Istituto Nazionale dei Tumori , Divisione di Oncologia Medica B" are
8 trials for "Female" genders and 6 trials for "All" genders.
Clinical Trials Status at Istituto Nazionale dei Tumori , Divisione di Oncologia Medica B
Currently, there are NaN active trials in "Istituto Nazionale dei Tumori , Divisione di Oncologia Medica B".
undefined are not yet recruiting,
undefined are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 8 completed trials in Istituto Nazionale dei Tumori , Divisione di Oncologia Medica B,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Istituto Nazionale dei Tumori , Divisione di Oncologia Medica B, 1 "Phase 1"
clinical trials were conducted, 8 "Phase 2" clinical
trials and 7 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".